Excimer laser refractive surgery in autoimmune diseases

Kohnen, Thomas

doi:10.1016/j.jcrs.2006.06.001

Cited by 11 publications

(8 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Maintain the integrity of the eyeball, with good predictability, stability and safety, a wider range of treatable refraction. More studies have indicated that the visual effect of LASEK is better compared to LASIK, which is another leap of excimer laser correction of ametropia after PRK and LASIK, and provides a new direction for excimer laser correction of ametropia [ 38 , 39 ]. However, it should be noted that LASEK surgery has two disadvantages: First, the postoperative recovery is slow, which usually takes about a week to restore normal vision; the second disadvantage is that postoperative Haze may appear [ 40 , 41 ].…”

Section: Analysis and Discussionmentioning

confidence: 99%

Excimer Laser Corneal Refractive Surgery in the Clinic: A Systematic Review and Meta-analysis

Zhang¹,

Li²,

Cen³

2022

Computational and Mathematical Methods in Medicine

View full text Add to dashboard Cite

Objective. To systematically evaluate the efficacy, safety, recovery speed, and long-term visual quality of excimer laser corneal refractive surgery and to provide evidence-based medicine for the promotion and use of excimer laser corneal refractive surgery. Methods. Randomized controls on excimer laser refractive surgery in Web of science, PubMed, EMBASE, ScienceDirect, Cochrane Library, China Knowledge Network (CNKI), China VIP Database, Wan Fang Database, and China Biomedical Literature Database (CBM) were searched by the computer. Randomized controlled trial (RCT) data were extracted independently by two researchers, and the risk of bias of each included RCT was assessed according to the Cochrane Handbook 5.1.0 criteria. Meta-analysis of the collected data was performed using RevMan5.4 statistical software. Results. In the end, 9 high-quality literatures were included, with a total of 4366 samples, and meta-analysis was used. There was no significant difference in uncorrected visual acuity WMD after excimer laser keratorefractive surgery, but there was a statistically significant difference in WMD in the safety of excimer laser keratorefractive surgery. The results of uncorrected visual acuity (close) indicated the following: Chi2 = 13.56, DF = 5, P = 0.02, and I2 = 100%; the results of uncorrected visual acuity (distance) indicated the following: Chi2 = 34.44, DF =5 (P < 00000), and I2 = 85%; the results of best corrected visual acuity (myopia) indicated the following: Chi2 = 0.65, DF = 3, P = 088 > 0.05, and I2 = 0%; the results of best corrected visual acuity (hyperopia) indicated the following: Chi2 = 1.80, DF = 3, P = 0.61 > 0.05, and I2 = 0%. Conclusion. Excimer laser corneal refractive surgery is safe and effective, with faster recovery and better long-term visual acuity treatment effect. However, more studies and follow-up with higher methodological quality and longer intervention time are needed for further validation.

show abstract

Section: Analysis and Discussionmentioning

confidence: 99%

Excimer Laser Corneal Refractive Surgery in the Clinic: A Systematic Review and Meta-analysis

Zhang¹,

Li²,

Cen³

2022

Computational and Mathematical Methods in Medicine

View full text Add to dashboard Cite

show abstract

“…No severe sight-threatening complications have been reported in those patients. Although there were some complications of laser refractive surgery in patients with controlled CVD, the risk to them was similar to those observed in patients without autoimmune diseases [3,[8][9][10]. On this condition, many authors concluded that LVC in patients with well controlled RA, SLE, or SpA may be beneficial and not burdened with an increased risk of corneal complications [1,5,10].…”

Section: Ocular Manifestations Of Selected Cvdmentioning

confidence: 74%

“…According to the recommendations of the Food and Drug Administration (FDA) and the American Academy of Ophthalmology (AAO), the well-controlled autoimmune diseases are currently considered as a relative contraindication for laser vision correction (LVC). In turn, uncontrolled autoimmune diseases constitute an absolute contraindication to refractive surgery [1][2][3][4][5][6][7]. The reason for that is potentially increased risk of an excessive inflammatory reaction in the eye tissues, resulting in vision-threatening corneal complications such as: severe dry eye disease, corneal opacities (haze), perforating ulcers, inflammatory infiltration or keratomalacia (corneal melting) [1,3,5,7].…”

Section: Autoimmune Inflammatory Disorders (Collagen Vascular Diseases)mentioning

confidence: 99%

“…In turn, uncontrolled autoimmune diseases constitute an absolute contraindication to refractive surgery [1][2][3][4][5][6][7]. The reason for that is potentially increased risk of an excessive inflammatory reaction in the eye tissues, resulting in vision-threatening corneal complications such as: severe dry eye disease, corneal opacities (haze), perforating ulcers, inflammatory infiltration or keratomalacia (corneal melting) [1,3,5,7]. Recent studies have attempted to verify whether and which collagen vascular diseases (CVD) pose an increased risk of corneal postoperative complications [5].…”

Section: Autoimmune Inflammatory Disorders (Collagen Vascular Diseases)mentioning

confidence: 99%

See 1 more Smart Citation

Systemic contraindications for laser vision correction – an overview

Pniakowska

Jurowski²,

Wierzbowska³

2022

Ophthatherapy

View full text Add to dashboard Cite

Laser vision correction (LCV) is a common corneal surgery for the treatment of refractive errors. The rapid development of LVC techniques make this procedures safe and efficient. Despite the high safety profile of corneal refractive surgery, there are however some clinical conditions that constitute absolute or relative contraindication for this procedures. The aim of the paper was to overview and summarise the currently known systemic contraindications for LVC.

show abstract

“…Autoimmune diseases are contraindications to keratorefractive surgery, including photorefractive keratectomy with mitomycin-C (PRKC MMC). [1][2][3][4][5][6] The proposed reasons are a risk for a higher postoperative inflammatory response, a potentially damaging effect on the postoperative healing properties of the cornea, and the theoretical possibility that surgery could trigger a latent predisposition to corneal melting and significant scarring. However, the relationship between corneal disease and autoimmune disease depends on the type of autoimmune disease.…”

mentioning

confidence: 99%

Photorefractive keratectomy with mitomycin-C for the treatment of compound moderate myopia with astigmatism in buccal pemphigus vulgaris

Taheri

Kheiltash

2007

Journal of Cataract and Refractive Surgery

View full text Add to dashboard Cite

We report a case of controlled buccal pemphigus vulgaris with compound moderate myopia with astigmatism that was treated with photorefractive keratectomy with mitomycin-C (PRKCMMC) in both eyes. The preoperative manifest refraction was À6.50 sphere and À5.5 À0.75 Â 20 in the right eye and left eye, respectively, with a best corrected visual acuity of 10/10 in both eyes. Seven months after surgery, the uncorrected visual acuity was 10/10 in both eyes. The manifest refraction was 0.75 sphere and 0.50 À0.75 Â 120 in the right eye and left eye, respectively. Haze was not detected in the follow-up examinations. Reepithelialization was complete 5 days after surgery in both eyes. The results show that PRKCMMC for compound moderate myopia with astigmatism in a patient with controlled pemphigus vulgaris may be an effective and safe treatment.

show abstract

Excimer laser refractive surgery in autoimmune diseases

Cited by 11 publications

References 4 publications

Excimer Laser Corneal Refractive Surgery in the Clinic: A Systematic Review and Meta-analysis

Excimer Laser Corneal Refractive Surgery in the Clinic: A Systematic Review and Meta-analysis

Systemic contraindications for laser vision correction – an overview

Photorefractive keratectomy with mitomycin-C for the treatment of compound moderate myopia with astigmatism in buccal pemphigus vulgaris

Contact Info

Product

Resources

About